Jiangxi Bio: First Post-Listing Monthly Return Shows Stable Share Capital and Full Public Float Compliance

Bulletin Express07-07

Jiangxi Institute of Biological Products Inc. (Jiangxi Bio) released its inaugural Monthly Return for the period ended 30 June 2026, confirming that no changes occurred in either its authorised or issued share capital during its first trading day on the Hong Kong Main Board.

Total Share Capital • Authorised/registered share capital stood at 308.38 million shares with a par value of RMB 1 each. • H-shares accounted for 307.09 million shares, while domestic shares totalled 1.29 million shares.

Issued Shares and Treasury Shares • Issued H-shares remained unchanged at 307.09 million; no treasury shares were held. • Domestic issued shares were steady at 1.29 million. • No share repurchases, cancellations, or issuances were reported.

Public Float • The company confirmed compliance with the Main Board’s minimum 25% public float requirement as of 30 June 2026.

Capital Instruments • The return recorded no outstanding share options, warrants, convertibles, or other equity-linked agreements.

Governance The filing was authorised by Chairperson and Executive Director Jing Yue, affirming adherence to all Hong Kong listing rules and regulatory obligations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1198210747?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-07 16:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198210747","market":"hk","top_or_hot":-1,"title":"Jiangxi Bio: First Post-Listing Monthly Return Shows Stable Share Capital and Full Public Float Compliance","media":"Bulletin Express","content":"<p>Jiangxi Institute of Biological Products Inc. (Jiangxi Bio) released its inaugural Monthly Return for the period ended 30 June 2026, confirming that no changes occurred in either its authorised or issued share capital during its first trading day on the Hong Kong Main Board.</p>\n<p>Total Share Capital  \n• Authorised/registered share capital stood at 308.38 million shares with a par value of RMB 1 each.  \n• H-shares accounted for 307.09 million shares, while domestic shares totalled 1.29 million shares.</p>\n<p>Issued Shares and Treasury Shares  \n• Issued H-shares remained unchanged at 307.09 million; no treasury shares were held.  \n• Domestic issued shares were steady at 1.29 million.  \n• No share repurchases, cancellations, or issuances were reported.</p>\n<p>Public Float  \n• The company confirmed compliance with the Main Board’s minimum 25% public float requirement as of 30 June 2026.</p>\n<p>Capital Instruments  \n• The return recorded no outstanding share options, warrants, convertibles, or other equity-linked agreements.</p>\n<p>Governance  \nThe filing was authorised by Chairperson and Executive Director Jing Yue, affirming adherence to all Hong Kong listing rules and regulatory obligations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jiangxi Bio: First Post-Listing Monthly Return Shows Stable Share Capital and Full Public Float Compliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJiangxi Bio: First Post-Listing Monthly Return Shows Stable Share Capital and Full Public Float Compliance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-07 16:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jiangxi Institute of Biological Products Inc. (Jiangxi Bio) released its inaugural Monthly Return for the period ended 30 June 2026, confirming that no changes occurred in either its authorised or issued share capital during its first trading day on the Hong Kong Main Board.</p>\n<p>Total Share Capital  \n• Authorised/registered share capital stood at 308.38 million shares with a par value of RMB 1 each.  \n• H-shares accounted for 307.09 million shares, while domestic shares totalled 1.29 million shares.</p>\n<p>Issued Shares and Treasury Shares  \n• Issued H-shares remained unchanged at 307.09 million; no treasury shares were held.  \n• Domestic issued shares were steady at 1.29 million.  \n• No share repurchases, cancellations, or issuances were reported.</p>\n<p>Public Float  \n• The company confirmed compliance with the Main Board’s minimum 25% public float requirement as of 30 June 2026.</p>\n<p>Capital Instruments  \n• The return recorded no outstanding share options, warrants, convertibles, or other equity-linked agreements.</p>\n<p>Governance  \nThe filing was authorised by Chairperson and Executive Director Jing Yue, affirming adherence to all Hong Kong listing rules and regulatory obligations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06915","symbol_name":"江西生物","start_time":0,"source_url":"","article_id":"1198210747","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198210747","pubTimestamp":1783413761,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jiangxi Institute of Biological Products Inc. (Jiangxi Bio) released its inaugural Monthly Return for the period ended 30 June 2026, confirming that no changes occurred in either its authorised or...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06915":"江西生物"},"translate_title":"江西生物：上市后首个月报表显示股本稳定公众持股量全面合规","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06915":1},"content_text":"Jiangxi Institute of Biological Products Inc. (Jiangxi Bio) released its inaugural Monthly Return for the period ended 30 June 2026, confirming that no changes occurred in either its authorised or issued share capital during its first trading day on the Hong Kong Main Board.\nTotal Share Capital  \n• Authorised/registered share capital stood at 308.38 million shares with a par value of RMB 1 each.  \n• H-shares accounted for 307.09 million shares, while domestic shares totalled 1.29 million shares.\nIssued Shares and Treasury Shares  \n• Issued H-shares remained unchanged at 307.09 million; no treasury shares were held.  \n• Domestic issued shares were steady at 1.29 million.  \n• No share repurchases, cancellations, or issuances were reported.\nPublic Float  \n• The company confirmed compliance with the Main Board’s minimum 25% public float requirement as of 30 June 2026.\nCapital Instruments  \n• The return recorded no outstanding share options, warrants, convertibles, or other equity-linked agreements.\nGovernance  \nThe filing was authorised by Chairperson and Executive Director Jing Yue, affirming adherence to all Hong Kong listing rules and regulatory obligations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1198210747","isCrawlerRequest":true}